June 16, 2024

Italian Government Takes Proactive Approach to Addressing Gender Dysphoria in Minors through Joint Discussion on Triptorelin Use

1 min read
Schillaci and Roccella Collaborating on New guidelines for Triptorelin Dysphoria

The Ministry of Health and the Ministry of Family have taken a proactive approach to addressing the complex issue of gender dysphoria in minors by initiating a joint discussion on the use of triptorelin, a puberty blocking drug. This discussion is being led by Ministers Orazio Schillaci and Eugenia Roccella. The two ministries released a joint statement announcing this initiative and summarizing the work done so far on gender dysphoria and the use of blockers.

The initiative follows a hearing with scientific societies involved in the issue of gender dysphoria in adolescents and a request made to the National Bioethics Committee to reevaluate the use of triptorelin in cases of gender dysphoria in minors. The ministries are also conducting a survey among regions regarding clinical monitoring, expenditures, and prescriptions of triptorelin for cases of dysphoria, and have requested a report from AIFA on the therapeutic indications for the drug.

A table of technicians and experts, whose composition will be finalized in the coming days, aims to develop new guidelines based on a review of scientific literature and experiences from other countries that are reevaluating their positions after widespread use of these drugs. The ministries are committed to ensuring evidence-based guidelines and best practices are followed when it comes to treating gender dysphoria in minors. Stay tuned for updates as this important issue continues to unfold.

Leave a Reply

Copyright © All rights reserved. | Newsphere by AF themes.